Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
71 Results Found
AHA 340B Advocacy Alliance Bulletin - October 30, 2025
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1, 2026.
340B Advocacy Alliance Bulletin - July 29, 2025
Register for Aug. 1 AHA Site-neutral Advocacy Alliance Call.
AHA 340B Advocacy Alliance Bulletin - September 24, 2025
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges against the state’s law protecting 340B pricing for contract pharmacy arrangements.
AHA 340B Advocacy Alliance Newsletter
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B covered entities.
Chair File: The Importance of Legal Advocacy
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get the resources we need to care for our communities.
Chair File: Leadership Dialogue — Legal Advocacy to Protect Hospitals With AHA General Counsel Chad Golder
Chad Golder, general counsel at the AHA, recently joined me on the Leadership Dialogue for a conversation on our current legal environment, what the AHA is doing on behalf of members, and what hospital and health system leaders can do to help.
AHA Statement on 340B Rebate Guidance
The AHA looks forward to reviewing HRSA’s 340B rebate guidance in more detail and working with the agency on this issue. However, we are concerned that this guidance authorizes a significant departure from how the 340B program has successfully operated for decades and sets a dangerous precedent for possible harmful expansions in the future.
AHA 340B Advocacy Alliance Bulletin - AHA Regulatory Advisory on 340B Rebate Pilot Program
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.